BI 425809: Clinical Trials

1 trial of BI 425809, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow BI 425809: new trials by email Literature Review of BI 425809 trials Research Report on BI 425809

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia
BI 425809, Placebo - Schizophrenia
Phase 2CompletedBoehringer Ingelheim2002019-04-152023-11-18

Conditions studied

Schizophrenia (1)

Sponsors

Boehringer Ingelheim (1)

Countries

Australia (1)  ·  Canada (1)  ·  France (1)  ·  New Zealand (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 32036587, PMID 39759424

NIH funding

2018 (1)